Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)
CUSIP: 28658R106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 68,580,003
- Total 13F shares
- 49,893,947
- Share change
- -2,047,023
- Total reported value
- $61,871,600
- Price per share
- $1.24
- Number of holders
- 68
- Value change
- -$2,503,034
- Number of buys
- 36
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 28658R106?
CUSIP 28658R106 identifies CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28658R106:
Top shareholders of CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AI ETI LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,009,400
|
$62,617,500 | — | 12 Aug 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
46%
|
31,419,267
|
$38,331,506 | — | 31 Mar 2025 | |
| Pontifax Management 4 G.P. (2015) Ltd. |
13D/G
|
Pontifax VI G.P. L.P. |
7.7%
|
5,206,380
|
$12,911,822 | $0 | 27 Jun 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3.3%
|
2,296,424
|
$2,801,639 | — | 31 Mar 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
2.9%
|
1,999,415
|
$2,439,286 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
2.7%
|
1,850,118
|
$2,257,144 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
1,502,556
|
$1,833,118 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2.2%
|
1,500,000
|
$1,830,000 | — | 31 Mar 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.5%
|
1,047,000
|
$1,277,340 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.5%
|
1,040,115
|
$1,268,940 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,000,000
|
$1,220,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
673,811
|
$822,261 | — | 31 Mar 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.98%
|
669,803
|
$817,160 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.85%
|
585,728
|
$716,000 | — | 31 Mar 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.81%
|
553,816
|
$675,656 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.75%
|
514,398
|
$627,566 | — | 31 Mar 2025 | |
| Brett Kaplan |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
577,500
mixed-class rows
|
$618,450 | — | 13 Jan 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.68%
|
463,654
|
$565,658 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.65%
|
442,661
|
$540,045 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.56%
|
382,225
|
$466,314 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.55%
|
378,536
|
$461,814 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.45%
|
306,424
|
$373,837 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
300,886
|
$367,081 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.37%
|
255,114
|
$311,239 | — | 31 Mar 2025 | |
| Allostery Investments LP |
13F
|
Company |
0.36%
|
244,988
|
$298,885 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.35%
|
241,935
|
$295,161 | — | 31 Mar 2025 | |
| Valerie Morisset |
3/4/5
|
EVP, R&D AND CSO |
—
mixed-class rows
|
41,515
mixed-class rows
|
$249,910 | — | 19 Jul 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.29%
|
200,000
|
$244,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
176,979
|
$215,915 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.26%
|
175,088
|
$213,608 | — | 31 Mar 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.21%
|
145,760
|
$177,827 | — | 31 Mar 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.21%
|
145,000
|
$176,900 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
134,300
|
$163,846 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
120,742
|
$147,305 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.17%
|
119,320
|
$145,570 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.17%
|
114,000
|
$139,080 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.13%
|
89,400
|
$109,068 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
82,754
|
$100,960 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
70,093
|
$85,513 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
64,914
|
$79,195 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
63,379
|
$77,322 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
58,730
|
$71,650 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
53,662
|
$65,468 | — | 31 Mar 2025 | |
| Emily Pimblett |
3/4/5
|
SVP, Finance & CAO |
—
mixed-class rows
|
133,888
mixed-class rows
|
$63,821 | -$1,540 | 18 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
42,506
|
$51,857 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
40,125
|
$48,953 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.06%
|
39,034
|
$47,621 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
37,287
|
$45,491 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
27,660
|
$33,745 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
24,782
|
$30,229 | — | 31 Mar 2025 |
Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q2 2025
As of 30 Jun 2025,
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,893,947 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., CANTOR FITZGERALD, L. P., CITIGROUP INC, Affinity Asset Advisors, LLC, VANGUARD GROUP INC, Deep Track Capital, LP, Kynam Capital Management, LP, TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., and DIADEMA PARTNERS LP.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
76
Q2 2025 holders
68
Holder diff
-8
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.